Catalent creates commercial excellence role
Appoints Jeremie Trochu to the position
Trochu joins Catalent from General Electric, where he was most recently general manager of sales resource optimisation within the firm’s healthcare division. Prior to that, he was commercial transformation leader for GE Healthcare.
‘As Catalent continues to grow with investments in acquisitions, drug delivery technologies, new capabilities and site expansions, I am excited to have Jeremie join the Catalent team to help enhance our sales capabilities across all offerings. He brings significant commercial experience to Catalent,’ said Will Downie, senior vice president of global sales and marketing at Catalent.
You may also like
Manufacturing
Ardena acquires Catalent's US oral dose manufacturing facility, adding further bioanalytical services
The CRO/CDMO will now integrate its advanced late-stage and small-scale commercial oral drug product manufacturing services with an extended list of bioanalytical services, enhancing its offering to clients in the North American region
Manufacturing
Catalent Boston adds to oral spray drying capacity to support late-stage clinical trials and commercialisation
Catalent, the leading provider of oral drug development solutions, bioavailability enhancing technologies and flexible manufacturing, has completed a series of upgrades to its large-scale spray drying unit (GEA PSD-4) at its Boston (MA, US) facility